VERU Veru Inc

Price (delayed)

$2.46

Market cap

$41.94M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.58

Enterprise value

$20.75M

?
Relative Growth: Rel. Growth: 15
Relative Strength: Rel. Strength: 30
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 12

Veru is a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of cardiometabolic diseases, oncology, and ARDS. The Company’s drug development program includes two late-stage ...

Highlights
The EPS has soared by 74% YoY and by 26% from the previous quarter
The net income has soared by 58% YoY and by 2.5% from the previous quarter
The quick ratio has soared by 86% YoY but it has contracted by 27% from the previous quarter
The equity has soared by 85% YoY but it has contracted by 18% from the previous quarter

Key stats

What are the main financial stats of VERU

VERU stock price

How has the Veru stock price performed over time
Intraday
-1.6%
1 week
6.03%
1 month
-6.82%
1 year
-27%
YTD
14.95%
QTD
-21.41%

Financial performance

How have Veru's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$19.19M
Net income
-$13.61M
Gross margin
N/A
Net margin
N/A
The net income has soared by 58% YoY and by 2.5% from the previous quarter
The operating income has increased by 46% year-on-year

Price vs fundamentals

How does VERU's price correlate with its fundamentals

Growth

What is Veru's growth rate over time

Valuation

What is Veru stock price valuation
P/E
N/A
P/B
1.39
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has soared by 74% YoY and by 26% from the previous quarter
The equity has soared by 85% YoY but it has contracted by 18% from the previous quarter
The P/B is 65% below the 5-year quarterly average of 4.0 and 17% below the last 4 quarters average of 1.7

Efficiency

How efficient is Veru business performance
Veru's ROE has soared by 67% YoY and by 13% from the previous quarter
The ROA has soared by 58% YoY and by 8% from the previous quarter
The return on invested capital has grown by 18% year-on-year and by 8% since the previous quarter

Dividends

What is VERU's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for VERU.

Financial health

How did Veru financials performed over time
The quick ratio has soared by 86% YoY but it has contracted by 27% from the previous quarter
Veru's current ratio has soared by 83% YoY but it has decreased by 29% from the previous quarter
VERU's debt is 91% smaller than its equity
The equity has soared by 85% YoY but it has contracted by 18% from the previous quarter
The debt to equity has dropped by 57% year-on-year but it is up by 13% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.